Phil LaFoy Receives 2013 NCPA Prescription Drug Safety Award

Share |

Orlando, Fla., Oct. 14, 2013 - Phil LaFoy, RPh, owner and president of Tennessee's Blount Discount Pharmacy was named the winner of the 2013 NCPA Prescription Drug Safety Award. Sponsored by Purdue Pharma, L.P., the award recognizes pharmacists who have reached out in their communities to provide education on the benefits of the correct use of prescription drug products and the hazards associated with their misuse. He received the award on Monday, October 14 during the Second General Session of the 115th Annual NCPA Convention and Trade Exposition held October 12-16 in Orlando.

"Phil LaFoy is a very deserving recipient of the 2013 NCPA Prescription Drug Safety Award," said NCPA President Donnie Calhoun, RPh, a pharmacy owner in Anniston, Ala. "An important component of drug safety is adherence, and Phil has been an innovator in this arena with Medicine-On-Time. The medicine repacking program helps patients, especially those having trouble handling complex regimens, become more complaint. This forward-thinking approach is helping to shrink the disturbing $290 billion a year wasted on the improper use of medications according to NEHI estimates."

Blount Discount Pharmacy is comprised of four independent community pharmacies located in Maryville and Alcoa, Tenn., where LaFoy is active with the local Substance Abuse Prevention Action Team. A 1983 graduate of the Samford University School of Pharmacy, he now serves as an adjunct faculty member there and also at Eastern Tennessee State University and South College. In addition to being an active member of NCPA, he is past chair of the Tennessee Society of Independent Pharmacists and is also a member of the Tennessee Pharmacists Association, the American Society of Consultant Pharmacists and the American Pharmacists Association.

"Purdue Pharma is proud to sponsor the NCPA Drug Safety Award, and believes the example set by winners such as Phil LaFoy should be emulated by others," said Steve Seid, Executive Director of National Accounts & Trade Relations for Purdue. "Pharmacists are on the front lines of health care and are the last person a patient typically sees before taking a prescription drug. So their insight into how to limit medication misuse or simply to maximize health benefits is vital. We applaud their continuing efforts and pharmacists like Phil who are bringing workable solutions to the table."


The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies. Together they represent an $88.7 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 300,000 individuals, including over 62,000 pharmacists. To learn more go to or read NCPA's blog, The Dose, at

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at

Ask Your Family Pharmacist TM